Saswat Mohapatra, PhD, received his doctorate in cancer biology from the Indian Institute of Chemical Biology and Academy of Scientific & Innovative Research, in India. In his doctorate research, Mohapatra was involved in the development of novel peptides and small molecules which target microtubules and mitochondria for combination therapy of breast cancer, cervical cancer and NSCLC. He later moved to the Cumming School of Medicine, University of Calgary, Canada as a postdoctoral associate to pursue further studies in cancer-specific immunotherapy. There he studied the role of various immune cells like TR1, neutrophils, iNKT and MAIT cells in cancer and various autoimmune disease-specific microenvironments. Mohapatra joined the Theodorescu Lab to explore and develop bladder cancer-specific chemo-/immuno-therapeutic interventions with a primary focus on understanding adaptive and acquired resistant factors of bladder cancers.